Combining peptide therapeutics with a versatile disposable pen platform

13/10/2022

Nemera’s device has adaptability as its core, being customisable to drug, therapy, and customer requirements. Plus expert assistance is on hand throughouts its life cycle.

The structural complexity of these molecules triggers immune response in a specific, efficient and safe way for the patient. This therapeutic area is no longer restricted to diabetes alone. It now encompasses cardiovascular diseases, inflammatory bowel diseases, oncology, and more. This all suggests that this sector has a promising future.

In order to meet this specific trend in pharma, Nemera is offering a disposable, variable dose and manual pen platform: PenVario. In addition to simplicity of use for patients, reliability and quality for pharma partners, the versatility of this platform is its key element.

Offering a wide range of possibilities, through a platform approach, enables economies of scale and ensures product robustness.


To read the full magazine : HERE


About Nemera
As a world-leading drug delivery device solutions provider, our purpose of putting patients first enables us to design and manufacture devices that maximize treatment efficacy. We are a holistic partner and help our customers succeed in the sprint to market of their combination products. From early device strategy to state-of-the-art manufacturing, we’re committed to the highest quality standards. Agile and open-minded, we work with our customers as colleagues. Together, we go the extra mile to fulfill our mission.
For more information, visit www.nemera.net

Latest News

ESG

The Gender Equality Index at Nemera – Year 2021

25/02/2022

L’Index, se calcule à partir de 4 à 5 indicateurs selon que l’entreprise fait moins ou plus de 250 salariés et prend en compte : L’écart de rémunération femmes-hommes, L’é...

Continue Reading